<DOC>
	<DOCNO>NCT00136292</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics single dose daptomycin patient age 2-17 year old suspect proven gram-positive infection receive standard antibiotic therapy . The tolerability single dose daptomycin patient also assess .</brief_summary>
	<brief_title>Study Single Dose Daptomycin Pediatric Patients With Gram-Positive Infection Which They Are Receiving Standard Antibiotics</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>217 year old Suspected diagnosed grampositive infection patient receive standard antibiotic therapy Clinically stable evidence hemodynamic instability 72 hour window prior enrollment , history evidence renal hepatic compromise , clinically significant alteration fluid/electrolyte homeostasis Creatinine clearance ( CLcr ) â‰¥ 80 ml/min/1.73 m2 determine Schwartz equation Creatine phosphokinase ( CPK ) level within normal limit Known allergy daptomycin History clinically significant cardiovascular , renal , hepatic , pulmonary ( wellcontrolled asthma acceptable ) , gastrointestinal , endocrine , hematologic , autoimmune disease Pneumonia sole grampositive infection Use HMGCoA reductase inhibitor systemic antihyperlipidemic agent within 7 day prior study drug administration expect use 3 day postdose Clinically significant abnormal laboratory test result ( include electrocardiogram [ ECGs ] ) , determine Investigator Body mass index ( BMI ) outside 5th 95th percentile age History ( personal 1st degree relative ) clinically significant muscular disease , nervous system , seizure psychiatric disorder Expected intramuscular ( IM ) injection within 3 day follow dosing Expected surgical procedure ( ) within 3 day follow dosing Unexplained muscular weakness Rhabdomyolysis , myositis septic shock</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Gram-Positive Infection</keyword>
</DOC>